Literature DB >> 10933801

Phosphorylation of human p53 on Thr-55.

A Gatti1, H H Li, J A Traugh, X Liu.   

Abstract

The pleiotropic function of p53 is believed to be greatly influenced by phosphorylation, and several sites on p53 are known to be targets for distinct protein kinases. In this study, we observed that affinity-purified p53 from overexpressing cells was phosphorylated by a co-purified protein kinase in vitro. To identify phosphorylation site(s), the resulting phosphorylated p53 protein was subjected to primary and secondary proteolytic cleavage, and phosphopeptides were fractionated by a two-dimensional peptide gel system. Phosphoamino acid analysis and manual Edman degradation of the isolated phosphopeptides enabled us to unequivocally identify Thr-55 as the major phosphorylation site on p53. Furthermore, comparative phosphopeptide mapping data suggest that DNA-PK is not the kinase responsible for this phosphorylation. Significantly, using a phospho-specific antibody for Thr-55, we have shown that Thr-55 is indeed phosphorylated in vivo. These data define Thr-55 as a novel phosphorylation site and for the first time show threonine phosphorylation of human p53.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933801     DOI: 10.1021/bi992454i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Ser 524 is a phosphorylation site in MUTYH and Ser 524 mutations alter 8-oxoguanine (OG): a mismatch recognition.

Authors:  Sucharita Kundu; Megan K Brinkmeyer; Richard A Eigenheer; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2010-08-17

2.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 3.  Posttranslational phosphorylation of mutant p53 protein in tumor development.

Authors:  Manabu Matsumoto; Mutsuo Furihata; Yuji Ohtsuki
Journal:  Med Mol Morphol       Date:  2006-06       Impact factor: 2.309

4.  A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

5.  Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.

Authors:  Chul Won Lee; Josephine C Ferreon; Allan Chris M Ferreon; Munehito Arai; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-20       Impact factor: 11.205

6.  Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.

Authors:  T Buschmann; O Potapova; A Bar-Shira; V N Ivanov; S Y Fuchs; S Henderson; V A Fried; T Minamoto; D Alarcon-Vargas; M R Pincus; W A Gaarde; N J Holbrook; Y Shiloh; Z Ronai
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

7.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

8.  Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.

Authors:  Geoffrey P Shouse; Xin Cai; Xuan Liu
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

9.  Highly efficient and selective enrichment of phosphopeptides using porous anodic alumina membrane for MALDI-TOF MS analysis.

Authors:  Yuebo Wang; Wei Chen; Jianshuang Wu; Yinlong Guo; Xinghua Xia
Journal:  J Am Soc Mass Spectrom       Date:  2007-04-29       Impact factor: 3.109

10.  High glucose-induced p53 phosphorylation contributes to impairment of endothelial antioxidant system.

Authors:  Yong Wu; Sangkyu Lee; Selene Bobadilla; Sheng Zhong Duan; Xuan Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-30       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.